net dbt
peel back onion leav less visibl
result good enough where sourc upsid
quarter surfac fairli solid total organ growth
even account contribut anim health transit servic
agreement na dental consum came organ growth estim na
dental equipment/na medical/intern dental beat organ growth
estim total number better time dynam around
intern dental shift oper expens leverag one-tim
save still posit leav less room upsid remaind
year increas number also note signific dental
exposur less expos on-going medicar debat weigh
broadli healthcar healthcar servic perform without identifi
catalyst drive growth upsid see risk/reward balanc therefor reiter
neutral rate increas price object
ev/ebitda roll forward one year previou valuat
increas ep estim ep
driver chang flow-through beat
better total margin pull-through lower share count model assum high
singl digit basi point ebit margin expans next year
upcom event catalyst
expect next focu point center around demand trend industri color
updat manag cours quarter includ bank
america merril lynch healthcar confer may also look
addit intra-quart updat increment growth prioriti addit
given compani focu post-spin
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one world largest distributor
dental medic product also provid
solut broad rang financi servic
primarili fragment custom base
compani headquart melvil new york
oper countri
remain market leader experienc
growth headwind still trade premium
valuat peer group compani
share gainer across key market dental
busi also see acceler contribut
equip side transit
trend still remain difficult predict na
medic see moder growth due multi-
ep growth continu oper
rais top end ep guidanc
believ gain share dental medic busi
expect sale continu sale littl impact
compani expect total revenu
exclud intern sale local currenc
adjust oper margin y/i
non-gaap ep versu growth y/i
dental sale intern growth local currenc
na growth includ consum compani believ
continu gain market share
id took place cologn german mid-march typic result lower
sale higher sale
cash flow oper quarter
continu believ compani strong cash flow full year
increas top end ep rang compar
anim busi spun feb
classifi discontinu oper current quarter
guidanc year continu oper previous announc
assum fx consist current level
assum end market remain stabl consist current
believ percentag point growth market core
cad/cam one highlight id
believ dental practic product within year
medic offic visit low quarter yet compani strong growth
despit reduct offic visit relat flu
tool includ advanc websit manag tool improv
on-line market autom digit commun
smileimag provid integr practic manag system
dentrix better bill practic manag electron code
market penetr digit impress
less practition digit prosthet devic
high market still avail
imag penetr
compani see relat oper margin
strong quarter regard oper margin
realli came oper expens reduct
oper expens reduct achiev compani
doesnt expect reoccur
wont bp full year
specialti percentag consum
full year basi includ implant ortho endo
within implant bone regener product
rang ep go compani retir quarter risk
gotten past toughest quarter year
rais top end compani came ahead
expect
rais guidanc beat
investor need care look one month data
start weak finish strong
march strong consum
dental market stabl consum particular
fx littl higher first half subsid
ep basi fx neg impact quarter
growth strategi work well hasnt work
would like see captur better share wallet oral
would like see compani align program grow
oper margin fx oper margin expans much
fx skew margin much benefit compani get cog sg
impact oper margin small relat fx sale
cog opex convert rate realli mix issu
littl cog line
specif opex repeat
expens compani abl reduc wont
expect bulk save occur
mani categori tri continu expens reduct
expens relat employe relat expens
half beat relat activ wont occur
balanc number thing
cadenc sale
short quarter sale
think sale rel even throughout year
price object base stand-alone ev/ebitda
previous remain busi follow spin-off merger
anim health busi lower end compani histor
trade rang account less visibl growth/margin opportun
upsid risk po stronger expect dental consumable/equip sale
either new relationship sirona share win cost ration downsid
risk uncertainti creat ftc complaint alleg price conspiraci
henri schein/patterson companies/benco dental suppli wors expect
share gain sirona-rel revenu new competit amazon creat
signific growth margin pressur segment
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
